Research with Dr. SanaChildren's health research, explained
Home / Diseases / SSPE
Rare · Measles-linked

SSPE (Subacute Sclerosing Panencephalitis)

A rare, fatal brain disease that can appear years after measles

Dr. Sana Fatima Updated 8 November 2026 8 min read Draft · awaiting Dr. Sana's medical review

At a glance

  • SSPE is a slow brain disease caused by measles virus that stays hidden in the brain after a child seems to have recovered from measles 1.
  • It usually starts 7 to 10 years after the measles infection 3.
  • About 1 in 10,000 people who catch measles develop SSPE, but the risk rises to about 1 in 600 when measles strikes before the first birthday 2.
  • There is no cure. Most patients die within 1 to 3 years of diagnosis, though some live longer 1.
  • Pakistan recorded more than 17,000 measles cases in 2025, and one Peshawar neurologist reported 90 confirmed SSPE cases in the year to September 2026 2.
  • Two doses of measles vaccine prevent measles, and the vaccine cannot cause SSPE 12.

What it is

When a child gets measles, the virus usually leaves the body after a few weeks. In rare cases a damaged form of the virus survives inside brain cells. Years later it slowly spreads from cell to cell, causing inflammation and destroying the brain 11Subacute sclerosing panencephalitis — MedlinePlus Medical Encyclopedia, U.S. National Library of Medicine, reviewed August 2026. medlineplus.gov55SSPE Clinical Practice Guideline 2026 — Research Group on Prion Disease and Slow Virus Infection, Ministry of Health, Labour and Welfare, Japan, March 2026. prion.umin.jp.

SSPE cannot spread from one person to another. The child caught measles years earlier; SSPE is a late after-effect of that infection.

Symptoms

SSPE moves through stages 1:

  • Stage 1: changes in personality or behaviour, mood swings, falling school marks, forgetfulness. This can last up to about 6 months and is easy to mistake for a behaviour problem.
  • Stage 2: sudden jerks of the arms, legs or head (myoclonic jerks), muscle spasms, fits (seizures), loss of vision and memory.
  • Stage 3: the jerks are replaced by stiffness and twisting movements. The child loses the ability to walk, speak and eat.
  • Stage 4: the parts of the brain controlling breathing, heart rate and blood pressure are damaged, leading to coma.

See a doctor urgently if

  • A child who had measles in the past (even years ago) starts having repeated sudden jerks or drops, especially every few seconds 1.
  • School performance or behaviour changes noticeably with no clear reason, in a child who had measles 44Subacute Sclerosing Panencephalitis — National Organization for Rare Disorders (NORD). rarediseases.org.
  • A child has new fits, loss of vision, or loses skills they already had.
  • A child has not completed their measles vaccines — catch up now 1.

Who is most at risk

  • Children who catch measles before age 2, and especially before age 1 22Doctors say rare, fatal measles-linked condition rising in Pakistan — Gavi VaccinesWork, 15 October 2026. gavi.org.
  • Boys are affected more often than girls 1.
  • Places with low measles vaccination and large outbreaks. Doctors in Khyber Pakhtunkhwa report the heaviest caseload in Pakistan 2.

How it is diagnosed

Doctors combine the child's story with tests 15:

  • Measles antibodies in the spinal fluid (lumbar puncture). A raised measles antibody level in the cerebrospinal fluid is the key test and is required for diagnosis 5.
  • EEG (brain-wave test). It typically shows repeating bursts of activity at regular intervals, often matching the jerks 5.
  • Brain MRI, an eye examination (the retina can be affected) and a careful measles and vaccination history 1.

Treatment

There is no cure 1. Care aims to slow the disease and keep the child comfortable:

  • Medicines for fits and jerks chosen by the neurologist 1.
  • Antiviral and immune treatments such as inosine pranobex (isoprinosine), with or without interferon given into the spinal fluid, are used in some centres. Benefit is usually small and often temporary 1566Gascon GG et al. Combined oral isoprinosine–intraventricular alpha-interferon therapy for SSPE — J Child Neurol, 2003. pubmed.ncbi.nlm.nih.gov.
  • Nutrition, physiotherapy, feeding support and palliative care as the disease progresses 1.

Doses and the choice of drugs must be decided by the child's specialist.

Prevention

  • Measles vaccine is the only protection. Two doses are almost completely protective 2.
  • The measles vaccine cannot cause SSPE 1.
  • In Pakistan, measles vaccine is free in the routine schedule. Pakistan ran a measles-rubella campaign for more than 35 million children in November 2025 2.

The situation now (2025–2026)

  • Pakistan: more than 17,000 measles cases in 2025 (WHO), and 4,541 confirmed cases in the first quarter of 2026, 1,712 of them in Khyber Pakhtunkhwa (as of Gavi report, 15 Oct 2026) 2.
  • Peshawar: Dr Athar Khalili confirmed 90 SSPE cases at his clinic from January to September 2026, about 10 a month. Lady Reading Hospital reports three to four children arriving with SSPE complications daily 2.
  • No national register: Pakistan has no central SSPE registry, so the true number is unknown 2.
  • United States: 5,182 confirmed measles cases in 2026 as of 5 November, more than double the 2,289 in all of 2025 1111Measles Cases and Outbreaks — U.S. Centers for Disease Control and Prevention, updated 5 November 2026. cdc.gov.
  • A coming wave: Doctors in the Philippines and Israel warn that today's measles outbreaks will bring more SSPE over the rest of the 2020s, and have called for a global SSPE registry 1212Gilboa T et al. (Hadassah, Jerusalem): call for a global SSPE registry — Archives of Disease in Childhood, 2026. pubmed.ncbi.nlm.nih.gov1414SSPE cases after the 2018–2019 measles outbreak, Philippines — Emerging Infectious Diseases (CDC), November 2026. wwwnc.cdc.gov.

What the research says

  • Gascon GG et al., J Child Neurol 2003international randomised trial, 121 patients
    Adding interferon into the brain fluid to oral inosiplex gave no extra benefit; about one-third did well in both groups. Read the study 6
  • Japan SSPE Clinical Practice Guideline, March 2026national guideline
    Strongly recommends oral inosine pranobex, weakly recommends adding interferon into the brain fluid, and calls ribavirin, aprepitant and special diets unproven. Read the study 5
  • Garg RK et al., Encephalitis 2026systematic review, 77 long-term survivors
    62% first stabilised or improved, but only 42% were still doing well at last follow-up. Long survival may reflect the disease's own course more than treatment. Read the study 7
  • Ibrahim SH, Farooq H, Front Nutr 2023Karachi case series, 12 children
    A low-glycaemic-index diet reduced jerks by more than half in 7 of 12 children, but the effect was short-lived and there was no comparison group. Read the study 9
  • Oncel I et al., Pediatr Neurol 2020randomised placebo-controlled trial, 62 patients
    Aprepitant was safe but gave no clinical benefit at 6 or 12 months. Read the study 8
  • AIIMS New Delhi, 2025cohort of 144 patients
    About 23% had a good outcome and 48% died during follow-up. Read the study 10

For doctors Clinical summary

As of November 2026 no SSPE treatment has proven benefit in a well-run randomised trial 613. Non-randomised series report short-term stabilisation or improvement in roughly one-third to one-half of patients on isoprinosine-based regimens, but spontaneous plateaus and remissions (around 5%) confound these results, and remissions are usually temporary 13. No antiviral trial for SSPE is registered on ClinicalTrials.gov; the only registered SSPE study is a ketogenic-diet trial from Aga Khan University, Karachi (NCT05152771), with status unknown 15. A new oral measles polymerase inhibitor (GHP-88310) blocked measles transmission in animals in 2026; it has brain tissue drug levels from a single-dose animal study, but no CNS infection model and no SSPE data 16.

Every source behind this page, tagged by whether we read the full text or only the abstract, is listed on the SSPE source map — 85 documents, 51 read in full.

Questions parents ask

Is SSPE caused by measles?

Yes. SSPE is caused by measles virus that stays in the brain after the original infection. It usually appears 7 to 10 years later 13.

Can the measles vaccine cause SSPE?

No. The measles vaccine cannot cause SSPE 1. Vaccination is the only way to prevent it 2.

Can my child recover from SSPE?

Sadly, SSPE has no cure and is almost always fatal. A small number of children stay stable for long periods, and treatment can ease jerks and fits 17.

How rare is SSPE?

About 1 in 10,000 measles cases overall, but about 1 in 600 when a baby catches measles before age one 2.

How is SSPE diagnosed?

With a lumbar puncture to look for measles antibodies in the spinal fluid, an EEG showing a typical repeating pattern, and usually a brain MRI 15.

Is SSPE contagious?

No. A child with SSPE cannot pass it to others. Measles itself is highly contagious, which is why vaccinating everyone matters.

Myth vs fact

  • MythOnce a child recovers from measles, the danger is over.
    FactMeasles virus can hide in the brain and cause SSPE years later 1.
  • MythThe measles vaccine can cause SSPE.
    FactThe vaccine cannot cause SSPE; it prevents the measles infection that leads to it 1.
  • MythSpecial diets or imported medicines can cure SSPE.
    FactNo treatment has been proven to cure SSPE; diet studies are small and benefits short-lived 59.

Sources

  1. 1.Subacute sclerosing panencephalitis — MedlinePlus Medical Encyclopedia, U.S. National Library of Medicine, reviewed August 2026. https://medlineplus.gov/ency/article/001419.htm
  2. 2.Doctors say rare, fatal measles-linked condition rising in Pakistan — Gavi VaccinesWork, 15 October 2026. https://www.gavi.org/vaccineswork/doctors-say-rare-fatal-measles-linked-condition-rising-pakistan
  3. 3.Measles: Clinical Overview — U.S. Centers for Disease Control and Prevention, updated August 2026. https://www.cdc.gov/measles/hcp/clinical-overview/index.html
  4. 4.Subacute Sclerosing Panencephalitis — National Organization for Rare Disorders (NORD). https://rarediseases.org/rare-diseases/subacute-sclerosing-panencephalitis/
  5. 5.SSPE Clinical Practice Guideline 2026 — Research Group on Prion Disease and Slow Virus Infection, Ministry of Health, Labour and Welfare, Japan, March 2026. https://prion.umin.jp/guideline/pdf/guideline_SSPE_2026.pdf
  6. 6.Gascon GG et al. Combined oral isoprinosine–intraventricular alpha-interferon therapy for SSPE — J Child Neurol, 2003. https://pubmed.ncbi.nlm.nih.gov/14736075/
  7. 7.Garg RK, Pandey S, Rizvi I, Singhal S. Factors associated with long survival in SSPE: a systematic review — Encephalitis, 2026. https://www.encephalitisjournal.org/journal/view.php?doi=10.47936%2Fencephalitis.2026.00108
  8. 8.Oncel I et al. Aprepitant in the treatment of SSPE: a randomized, double-blind, placebo-controlled study — Pediatr Neurol, 2020. https://pubmed.ncbi.nlm.nih.gov/32718528/
  9. 9.Ibrahim SH, Farooq H (Aga Khan University, Karachi): low-glycaemic-index diet in children with SSPE — Frontiers in Nutrition, 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10406380/
  10. 10.George JA, Vishnu VY et al. (AIIMS New Delhi): SSPE cohort of 144 patients — 2025. https://pubmed.ncbi.nlm.nih.gov/40432323/
  11. 11.Measles Cases and Outbreaks — U.S. Centers for Disease Control and Prevention, updated 5 November 2026. https://www.cdc.gov/measles/data-research/index.html
  12. 12.Gilboa T et al. (Hadassah, Jerusalem): call for a global SSPE registry — Archives of Disease in Childhood, 2026. https://pubmed.ncbi.nlm.nih.gov/42791058/
  13. 13.Garg RK, Sharma S: review of disease-modifying therapy in SSPE — 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10081548/
  14. 14.SSPE cases after the 2018–2019 measles outbreak, Philippines — Emerging Infectious Diseases (CDC), November 2026. https://wwwnc.cdc.gov/eid/article/32/11/26-1395
  15. 15.Ketogenic diet in children with SSPE (NCT05152771) — ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT05152771
  16. 16.Oral antiviral GHP-88310 blocks measles transmission in ferrets — Contagion Live, 2026. https://www.contagionlive.com/view/oral-antiviral-ghp-88310-blocks-measles-transmission-ferrets

This page summarises published research for education. It is not a diagnosis or a treatment plan. Always speak to your child's doctor, and go to the nearest hospital in an emergency.

Keep reading